ArticleInternational journal of molecular sciences2022

Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.

Ramesh Pariyar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.